GeneID	MetaboliteID	CandidateAnnotation	SupportingSNPRecords	MinimumP	Scope	ThresholdP	Comparison	GenomeAnnotation
Glyma.01G170700	P00411	2-Amino-5-chloromuconate 6-semialdehyde	1	5.7350705212089e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P00412	2-Amino-2-methylpropanoate	1	6.40752418870849e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P01731	4-Aminophenylacetic acid	1	2.47780806276877e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P01926	Hyacinthacine A4	1	8.83759237603404e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P02405	Flumequine	1	7.5892522318164e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P03606	N-(gamma-Glutamyl)ethanolamine	1	1.49574262247256e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P04039	Pefloxacin	1	2.33433943778306e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P04147	Rubomycin F	1	1.03622430937322e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P05511	6-Aminopenicillanate	1	2.41088667276392e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P06787	4,1-Benzoxazepine	1	7.36907706675037e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P06935	Machaerol B	1	2.81726387657445e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P07081	O-Methylisoalangiside	1	2.47981917609783e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P07292	Demethylated antipyrine	1	2.25067211260615e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P07617	Nitrogen mustard	1	9.17377252381737e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P08205		1	3.78389969734035e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P08419	Niazicinin	1	4.06880336581706e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P08711	Xylogranatinin	1	2.89523333487035e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P09110	2-O-Caffeoylhydroxycitric acid	1	6.5009247267492e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P11012	Mofegiline	1	7.69547476276867e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P11212	Semicochliodinol B	1	7.63618902448104e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P11457		1	3.30555196675768e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P11811		1	6.46425533934739e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P12806	N-Hydroxysuccinimide	1	6.86004561795158e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P13121	Callysponginol sulfate A	1	8.95932094436314e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P13935	Malvidin 3-glucoside-5-(6-acetylglucoside)	1	2.61812342200083e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P13948	O-Desmethyl Gefitinib	1	3.83133861918097e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P15127	Quin-2 acetoxymethyl ester	1	2.29241009987457e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P15527	(1S,4R)-passicapsin	1	3.67990708040625e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P15561	WS75624B	1	4.68920491295381e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P15581		1	1.35680629447184e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P15582		1	9.59157022647854e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P15731	HDMBOA-Glc	1	9.92268297418523e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P15762	Aristoloterpenate II	1	7.95523803577584e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P16872	Methyl-4-O-caffeoylquinate	1	6.50057962810663e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P20017		1	5.03031950286651e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P21163	Bismurrayafoline A	1	4.15215427301292e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P22237	4'-hydroxytrazodone	1	4.04626948798997e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P22796	Argylioside	1	6.74556328367133e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P23820	Teucrolin D	1	1.31880437244959e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P24176	(R)-2-Methylimino-1-phenylpropan-1-ol	1	4.97185312791573e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P24212	4-Hydroxyphenylacetylglutamic acid	1	1.19126968423969e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P25296		1	5.27973703560016e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P25621	Pseudoanisatin	1	7.25588933632415e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P26245	N-Phenylacetylglutamic acid	1	2.91687048445467e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P26379	(2R,3R,5S,6R)-6-(Ethyl)-2-(S-pantetheinyl)-carbapenam-3-carboxylate	1	2.28316151722372e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P26977	Benzyl chloroacetate	1	1.53744448287014e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P28859	PA(10:0/13:0)	1	9.84697833708694e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P29700	Hyponine E	1	5.57820485534793e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P30823		1	1.0184463238003e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P31334		1	2.36546204788392e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P32073	Tibouchinin	1	5.53959531959634e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P32148	1-hexadecanoyl-2-(4-hydroxy-7-oxo-5E-heptenoyl)-sn-glycero-3-phospho-(1'-sn-glycerol)	1	6.32392482431244e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P34626	Microtoenin C	1	1.25052352289977e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P35147	Isocitral	1	6.99968857617793e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P39839		1	5.79293642985651e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P40759	Mibefradil	1	5.50049814095834e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P41060	13-Dihydrodaunorubicin	1	1.37022595714115e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P41319	Veralosine	1	3.80411967975603e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P41917	TMC 2A	1	2.59810134917635e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P45739	Pubescenine	1	1.24885178814789e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P47239		1	9.8096361367944e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P51069	N-(15-hydroxy-5Z,8Z,11Z,13E-eicosatetraenoyl)-ethanolamine	1	9.42265297273056e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P52380	(3E,5Z)-1,3,5-Heptatriene	1	5.37190708250232e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P53404	2-Chloro-4-[(dimethylcarbamoyl)amino]benzoic acid	1	8.20131764500326e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.01G170700	P53455	Quadranoside X	1	4.49397004436672e-11	overlap	1e-10	<	Wm82.a2.v1